Although the causes are different, totally blind people (without light perception) and night shift workers have in common recurrent bouts of insomnia and wake-time sleepiness that occur when their preferred (or mandated) sleep and wake times are out of synchrony with their endogenous circadian rhythms. In this article, the patterns of circadian desynchrony in these two populations are briefly reviewed with special emphasis on longitudinal studies in individual subjects that used the timing of melatonin secretion as a circadian marker. In totally blind people, the most commonly observed pattern is a free-running rhythm with a stable non-24-h circadian period (24.2-24.5 h), although some subjectively blind people are normally entrained, perhaps by residually intact retinoypothalamic photic pathways. Experiments at the cellular and behavioral levels have shown that melatonin can produce time dependent circadian phase shifts. With this in mind, melatonin has been administered to blind people in an attempt to entrain abnormal circadian rhythms, and substantial phase shifts have been accomplished; however, it remains to be demonstrated unequivocally that normal long-term entrainment can be produced. In untreated night shift workers, the degree and direction of phase shifting in response to an inverted sleepwake schedule appears to be quite variable. When given at the optimal circadian time, melatonin treatment appears to facilitate phase shifting in the desired direction. Melatonin given prior to a night worker's daytime sleep also may attenuate interference from the circadian alerting process. Because melatonin has both phase-shifting and sleep-promoting actions, night shift workers, who number in the millions, may be the most likely group to benefit from treatment.
Introduction
Both night shift workers and the totally blind with free-running circadian rhythms (BFRs) suffer the consequences of circadian desynchrony (CD) . In BFRs, CD occurs because the free-running circadian pacemaker drifts out of phase with the 24-h solar/social day. In night workers, CD occurs because the circadian pacemaker cannot reset quickly enough to achieve congruence with the inverted sleep-wake schedule. During periods of CD, sleep is undermined by interference from the circadian alerting signal, and alertness is reduced because wake time coincides with the timing of elevated circadian sleep propensity. In addition, there may be an accumulation of &dquo;sleep debt&dquo; from previous episodes of poor sleep. This article reviews research on circadian rhythms in the totally blind and in night shift workers with an emphasis on studies that have used the timing of endogenous melatonin as a marker rhythm. These studies illustrate how the longitudinal (repeatedmeasures) assessment of melatonin profiles can be used in human research to discern the pattern and dynamics of circadian phase shifting. We then examine the current evidence that melatonin administration can reduce the adverse effects of CD in BFRs and night shift workers by resetting the circadian pacemaker to a more favorable phase and/or by counteracting sleep disruption resulting from an untimely circadian alerting signal.
Melatonin and Total Blindness
Circadian Rhythms in Totally Blind People Because the environmental light-dark (LD) cycle is critical to the regulation of circadian rhythms in all species, abnormalities had been suspected in blind people for some time. However, the incidence and nature of these abnormalities became defined only after longitudinal assessments of circadian phase were made in individual blind people. Miles and coworkers (1977) were the first to use serial measurements of core body temperature and cortisol profiles to document a free-running circadian rhythm in a totally blind person with a severe recurrent sleep disturbance. The finding of free-running circadian rhythms was documented in a second individual by Orth and coworkers (1979) using serial measurements of cortisol secretion. A few years later, Lewy and Newsome (1983) reported the occurrence of abnormal melatonin rhythms in 6 of 10 subjects. In that study, 2 of the subjects were sampled every week for 4 weeks. Of these 2 subjects, 1 was found to have a free-running rhythm, and the other was found to have an apparently entrained rhythm but at an abnormal phase. Subsequently, several case reports were published confirming free-running rhythms in blind people (Arendt et al.,1988; Okawa et al., 1987) . In all instances, the free-running rhythms had a circadian period (tau) that was similar to sighted people living in temporal isolation and presumably reflected the period of an endogenous pacemaker(s) no longer entrained to environmental time cues. In 1992, we reported the results of our study of 20 totally blind people, living in normal society, whose circadian rhythms were assessed primarily by measuring the phase of melatonin production at regular intervals (Sack et al., 1992b) . Subjects were admitted to the Oregon Health Sciences University's Clinical Research Center (CRC) at approximately biweekly intervals for hourly blood sampling for 24 h. Their circadian rhythms followed several patterns. If their melatonin onsets were stable and occurred at a normal phase, then they were classified as &dquo;entrained, normal phase&dquo; (n = 3). If their melatonin onsets were stable but occurred at an atypical phase, then they were classified as &dquo;entrained, atypical phase&dquo; (n = 3). If the melatonin onsets shifted in linear proportion to the time interval between sampling, then subjects were classified as &dquo;free-running&dquo; (n = 11). There were 3 subjects in whom we were unable to discern a pattern. Of the 11 subjects with free-running rhythms, the circadian periods varied between individuals (mean = 24.55 ± 0.31 h, range = 23.86-25.08) but appeared to be remarkably stable within each individual. We were unable to discern any relationship between cause, duration, or age of onset of blindness and the pattern of melatonin rhythms in these subjects, and there was no correlation with the regularity of daily habits.
A few blind people have no subjective light perception but are, nevertheless, normally entrained via retinohypothalamic photic pathways that remain intact. For example, Czeisler and coworkers (1995) found bright light-induced suppression of endogenous melatonin in 3 blind people who had no conscious light perception. They concluded that photic information was conveyed to the circadian system via a separate visual subsystem in these patients. These subjects were not free running at the time of the study, and they did not have histories of sleep disorders.
To investigate in more detail the relationship between sleep propensity and the other rhythms, we studied a totally blind person (Nakagawa et al., 1992) using the &dquo;7-13&dquo; ultra-short sleep schedule developed by Lavie (1986) . The subject was a 44-year-old totally blind man who had been employed in the past but was unemployed at the time of the study. Nevertheless, he maintained a consistent nighttime sleep and daytime activity schedule. His &dquo;sleep gate,&dquo; the first trial containing at least 50% sleep of any sleep stage (Lavie, 1986) , delayed an average of 0.59 h each day, and his melatonin rhythm delayed an average of 0.57 h each day We concluded that the sleep propensity rhythm clearly free ran in parallel with the melatonin rhythm, presumably driven by a common oscillator.
Another intensive case study of a totally blind man was reported by Klein et al. (1993) . At the time of the study, the subject was a 63-year-old man who had suffered from recurring insomnia for at least the previous 28 years. Remarkably, he had kept a diary of his sleep-wake cycle for 15 of those years. From these diary data on sleep time and quality, a circadian period of 24.20 h was calculated, based on the assumption that his sleep disorder was caused by a free-running rhythm that went in and out of phase with his very consistent bedtimes. The subject then slept in a laboratory for 93 consecutive nights, and at periodic intervals his circadian phase was measured under constant conditions using core body temperature and cortisol as circadian markers. These serial assessments documented that his endogenous rhythms were free running with a period of 24.2 h, exactly as predicted from the diary data. Polysomnographic data confirmed that sleep disruption was directly related to CD. For example, total sleep time (TST) ranged from 405 min when the subject was in normal phase to 283 min when he was 180° out of phase. In addition, the study indicated that this totally blind individual's free-running period was an extremely consistent trait over many years that was not modified by daily exposure to nonphotic time cues, including a very regular 24-h sleep-wake cycle.
As illustrated by these cases, BFRs do not typically choose to sleep in synchrony with their endogenous sleep propensity rhythms, even if they are unconstrained by work or other obligations. The drive to sleep can be resisted for a while by most adults so that actual sleep times are usually structured by social cues. Maintaining social and family interactions usually is a high priority; therefore, selected sleep times may be only loosely coupled to the underlying circadian sleep propensity rhythm, resulting in shorter sleep duration and poor sleep quality when rhythms are out of phase. Although sleep disturbances are a common consequence of circadian misalignment, BFRs seem to vary considerably in their tolerance for CD. In our series, a number of subjects had free-running rhythms but modest sleep problems (unpublished data).
In summary, it is clear that total blindness is commonly associated with circadian rhythm abnormalities and that the most common abnormality is a nonentrained, free-running rhythm of about 24.2 to 24.5 h that probably reflects the intrinsic period of the endogenous pacemaker. When the endogenous rhythm is out of phase with the desired sleep time, then insomnia and daytime sleepiness result. The ideal therapy would be to entrain the endogenous rhythms to a 24-h cycle so that the endogenous sleep propensity rhythm overlaps the nighttime hours and the circadian alerting process overlaps the daytime hours. Although nonphotic interventions may be sufficient to phase shift some blind people (see Buxton et al., 1997 [this issue]), a pharmacological zeitgeber would be the most convenient substitute for the LD cycle.
Melatonin Treatment in Blind People In 1987, we reported our initial study of melatonin administration to totally blind subjects (Sack et al., 1987) , with additional data reported over the subsequent few years (Sack et al., 1990 (Sack et al., ,1991 . The strategy of treatment was based on the landmark animal studies of Redman and coworkers (1983) . In our study, 5 totally blind males (selected from the 20 subjects described previously), with consistent free-running melatonin rhythms, were given exogenous melatonin (5 mg by mouth at bedtime) for up to 3 weeks. Of the 5 subjects, 4 showed significant cumulative advances in the phase of their melatonin rhythms (7-16 h) compared to projections derived from their baseline circadian period determinations (Sack et al., 1991) . Cortisol rhythms were advanced in parallel with the melatonin rhythms. These phase advances were substantially greater than those reported previously for sighted people, presumably because they were cumulative and unopposed by the LD cycle.
The total number of blind people treated with melatonin in our studies and reported in the world literature remains quite small (Sack et al., in press-a). There have been only a few reports of satisfactory entrainment and these were not proven conclusively (Lapierre and Dumont, 1995; Palm et al., 1991; Sack et al., 1990) .
Although there is clear evidence of phase shifting, entrainment of BFRs is not easily achieved. The reasons for this remain unclear. It is possible that melatonin is not sufficiently potent to achieve the necessary phase shifts, particularly in subjects whose free-running periods are quite long (e.g., > 24.5 h). But subjects who have circadian periods of 24.1 to 24.3 h should require only a modest daily phase advance, within the range observed in both our studies of blind and sighted people. Another reason that entrainment may not occur is the relative lack of a phase-shifting response to melatonin characteristic of some people. For example, in an attempt to find the optimal parameters of melatonin administration, we administered doses of 0.5 and 10 mg per day for up to 8 weeks to 1 subject who was BFR; at both doses, phase shifts always were quite small and insufficient to produce entrainment (unpublished data). In some instances, subjects may not have taken the melatonin at exactly the optimal time to produce corrective phase shifts. Also, it may be that endogenous melatonin production interferes with the zeitgeber signal of exogenous melatonin. It remains an important goal for this area of research to demonstrate unequivocally entrainment of BFRs with melatonin or any other nonphotic intervention.
A~e T~e Bene~ts c~Me~o~m T~~eMt to
Are There Benefits of Melatonin Treatment to Blind Subjects from a Direct Sleep-Promoting Effect?
Melatonin may not be able to entrain all patients; however, it may be able to provide symptomatic relief when taken at night during episodes of CD because of a direct sleep-promoting effect. The overall evidence for a soporific effect from melatonin is addressed elsewhere in this issue (Zhdanova and Wurtman, 1997; Lavie, 1997) .
We recently hypothesized that melatonin may promote sleep by counteracting the daytime alerting process generated by the circadian system (Sack et al., 1997) . This model postulates that both the phase-shifting and sleep-promoting effects of melatonin are mediated by receptors in the suprachiasmatic nuclei (SCN) (Reppert, 1997 [this issue]). Normally, the circadian alerting signal opposes the expression of sleep drive that accumulates during the day. This buildup in sleep drive is proportional to the duration of prior wakefulness (the &dquo;homeostatic&dquo; principle of sleep regulation). At night (in normally entrained individuals), the circadian alerting signal wanes and the accumulated sleep drive is expressed until it is dissipated and the circadian pacemaker begins to generate an alerting signal the following morning. However, in BFRs, when rhythms are desynchronized, the alerting process occurs during the night and sleep is disrupted.
Melatonin may be able to counteract this alerting signal, permitting more normal sleep. In this sense, melatonin may not produce sleepiness; rather, it permits or releases sleep propensity that otherwise would be opposed by the circadian system. Our concept is similar to &dquo;disconnecting the clock,&dquo; proposed by Dawson and Armstrong (1996) .
From systematic melatonin trials in BFRs, it may be possible to estimate the relative impact on sleep of phase shifting versus a direct hypnotic action of melatonin. If melatonin works mainly by circadian mechanisms, then it may be important for blind patients to take it scrupulously at the same time of the day, every day, so that it can function as a consistent circadian time cue (zeitgeber). On the other hand, if melatonin works mainly by counteracting the circadian alerting signal, then it need only be taken on the days that the patients are symptomatic, and the timing of administration is of less importance. Obviously, both mechanisms could underlie its therapeutic effects.
Melatonin and Night Shift Work
Melatonin as a Circadian Marker in Night Work Studies One of the fundamental questions in shift work research has been the extent to which night workers reset their circadian clocks in response to their inverted work and sleep schedules. The answer has relevance for many practical issues such as the rationale for shift work scheduling, the evaluation of workers who have shift work intolerance, and the efficacy of clock-resetting interventions (e.g., bright light exposure, melatonin administration). For example, in regard to the question of scheduling, if little or no resetting occurs, then it may be better to schedule rapidly rotating shifts to minimize the duration of CD.
On the other hand, if resetting occurs, then it may be better to schedule longer runs of night work so that workers have time to adapt.
The prevailing view at one time was that very little, if any, clock resetting occurred, even after prolonged runs of night work. However, it was difficult to be confident of this conclusion because methods for assessing circadian phase (e.g., rectal temperature, daily diaries) were subject to masking effects and other artifacts. A consensus is emerging that robust circadian phase shifting can occur but is highly variable and may be influenced by both intrinsic factors (e.g., age, sex, circadian propensity [&dquo;morningness&dquo; or &dquo;eveningness&dquo;]) and extrinsic factors (e.g., shift work schedule, intensity of social interaction, amount and timing of light exposure). This variability in circadian adaptation undoubtedly accounts for some of the large interindividual differences in tolerance to night shift work, but other factors are important as well, including motivational issues. Assessing the relative importance of all of these factors has awaited refined methodologies for measuring circadian phase in on-going field studies as well as quantifying the potency of potential phase-shifting influences in the environment such as bright light exposure.
Obtaining estimates of circadian phase in field studies of actual night workers is a formidable technical challenge; consequently, much of the physiological research has been done on laboratory volunteers in simulated shift work protocols. Core body temperature has been the most frequently used circadian phase marker in human research but is difficult to monitor in the field. Furthermore, if masking effects caused by sleep and activity are not well controlled, then inferences regarding circadian phase from temperature measurements may be in doubt. In a few simulated shift work experiments (not field studies), temperature data have been collected under constant conditions. As an alternative, mathematical corrections can be made on temperature data that subtract the hypothermic effect of sleep and thereby &dquo;unmask&dquo; the temperature data.
The use of melatonin as a phase marker has allowed assessments of circadian phase in night workers that are technically feasible, provide sharp resolution of circadian phase, and can be applied in repeated-measures research designs. In 1992, we reported that &dquo;per-manent&dquo; night workers had significant shifts in their melatonin rhythms, sometimes to an unexpected phase (Sack et al., 1992a) . Nine long-standing night workers were admitted to the general CRC for a 24-h period following their last shift of the week to collect blood samples for the measurement of their melatonin rhythms. Their profiles were compared to those of a group of normal subjects of similar ages who had been studied previously at the same time of the year. For 2 weeks prior to their admission to the CRC, all shift work and control subjects kept daily diaries of sleep quantity and quality. For all but 1 of the night workers, the melatonin rhythm was in a distinctly different phase from the typical day worker. The median melatonin onset for the night workers was at 1428 h (range = 14.8 h), statistically significantly different from the day workers' median onset of 2140 h (range = 2.7 h) (p < .007, Mann-Whitney U). Furthermore, the relationship of average sleep times to the average timing of melatonin production was quite abnormal in the night workers. In day-active subjects, melatonin almost invariably rose several hours prior to bedtime, whereas in night workers, melatonin onset lagged sleep onset by an average of 3.5 ± 2.4 h. In effect, the melatonin onset in the night workers was displaced an average of 5.6 h later than it should have been if it were in the normal relationship to the sleep onset. This difference between the timing of melatonin production and sleep times is a useful operational definition of CD.
In summary, in our initial study of permanent night workers, we found that melatonin rhythms were shifted to a distinctly different phase from day workers, only partially adapted to the inverted sleep-activity schedule. In some cases, melatonin rhythms were unexpectedly delayed with respect to timing of sleep. However, this study had a number of deficiencies; the sample size was small, sleep data were obtained from diaries rather than objective measures, and each worker had only one phase assessment. Therefore, we were unable to determine the direction and pattern of a shift. Finally, there was no attempted therapeutic intervention.
These considerations formed the background for our current studies of night shift workers on a &dquo;7-70&dquo; rotating schedule involving 7 consecutive 10-h shifts (2130 to 0730 h) alternating with 7 days &dquo;off.&dquo; This schedule is advantageous for circadian rhythm research because subjects have a lengthy opportunity (7 days) to adapt to both their work and off-work schedules ; thus, the dynamics of adaptation to the alternating schedules can be investigated. Also, subjects work precisely the same schedule every other week so that repeated measures can be made and the effects of treatments can be evaluated in a repeated-measures design.
The subjects (nurses and hospital clerical personnel) were between the ages of 21 and 55 years and had worked on the 7-70 shift for at least 6 months. All of the subjects participated in a double-blind crossover study of melatonin administration. For one 2-week block, they received melatonin (0.5 mg); for the other 2-week block, they received placebo (corn starch) formulated in identical gelatin capsules. Subjects were given melatonin (0.5 mg) at their usual bedtimes, that is, at 2100 to 2300 h during the off-work week and at 0800 to 1000 h during the work week. Subjects were blind to the treatment condition, and the order of treatment was randomized.
To monitor circadian phase, weekly assessments of the melatonin profile were obtained so that estimates of the direction and rate of phase shifting could be made. Just prior to beginning a run of night work, and just after, subjects were admitted to the CRC, where blood samples were obtained every hour for 24 h for determination of the dim light melatonin onset (DLMO) used as the marker of circadian phase. We also obtained estimates of circadian phase with sali-vary samples collected every hour while awake for 2 1 days in between CRC admissions; however, because ] these samples were collected in the field where the lighting conditions were not controlled, they provided . only a rough estimate of the intermediate phase between plasma melatonin measurements. However, the salivary melatonin data were valuable as an indicator of the direction of shift.
At this time, we have collected data on 24 subjects and have undertaken some preliminary analyses. At the end of their week off, the night workers were in about the same circadian phase as was a comparison group of day-active subjects participating in another study The melatonin onset for the night workers was at 1936 h; for the day workers, it was at 2112 h. Thus, night shift workers started their work week with their circadian clocks set at approximately a normal time.
A major question of this study was the magnitude and direction of the circadian phase shifts between the beginning and end of the 7-night workweek without treatment (placebo condition). In brief, we found substantial variability in both the magnitude and direction of phase shifting. In the study, 9 subjects showed no shift, 4 advanced their DLMO, 2 had partial delays, and 9 delayed 6 h or more. We currently are analyzing the data to see how much of the variability can be explained on the basis of demographic factors, light exposure, and so on. In summary, the variability in phase shifting of actual night workers is very impressive. A number of other groups have used the melatonin profile to assess night work-related phase shifts. Taken together, the results indicate variable responses. For example, Roden and coworkers (1993) found that 8 of 9 &dquo;permanent&dquo; night workers had no shifts in their melatonin rhythms following a 5to 6-day run. The 9th subject had a shifted profile, but this was attributed to maintaining an inverted sleep schedule on his days off. By contrast, Koller and coworkers (1994) found that after a 5-day run, 5 of 14 subjects on a similar work schedule had shifted their melatonin rhythms more than 6 h. The subjects who shifted their rhythms had significantly reduced exposure to light in the morning, which may have permitted greater phase delays. Quera-Salva and coworkers (1996) studied the temporal profile of urinary 6-sulfatoxymelatonin (the major metabolite of melatonin) excretion in 19 nurses who worked for 3 nights in a row. Of the 19 subjects, 6 appeared to shift an average of about 5 h, even after the brief run of night work, whereas the other 13 made no shift. The subjects who shifted their melatonin rhythms had daytime sleep bouts that were almost 2 h longer than those of the nonshifters.
Very little data are available on the within-subject variability in phase shifting. Does an individual phase shift after one run of night work but not the next, perhaps depending on light or social zeitgeber exposure ? Also, there is little information on the process of readaptation following a run of night work. Although it has been considered desirable to promote phase shifting, perhaps individuals who do not shift have an advantage by being &dquo;in phase&dquo; during their off-work (recreational) time.
Laboratory studies indicate that congruence of sleep with the circadian sleep propensity rhythm is a critical determinant of sleep duration and that correction of an abnormal phase relationship by a variety of strategies can improve sleep. To address this issue, we divided the group into definite &dquo;shifters&dquo; (greater than a 6-h phase shift, n = 10) and &dquo;nonshifters&dquo; (less than a 3-h phase shift, n = 7) and compared wrist actigraphic estimates of sleep during the placebo work and off-work weeks. Between-group comparisons showed that time in bed (TIB) was an average of 70 min longer per day during the workweek for shifters than for nonshifters (511 ± 72 vs. 441 ± 83 min, p < .01), and TST was an average of 100 min longer (441 ± 64 vs. 341 ± 82 min, p < .01). During the off-work week, there were no significant differences in either TIB (522 ± 52 vs. 543 ± 24 min, p = .32) or TST (445 ± 56 vs. 448 ± 58 min, p = .90) between the groups. Within-group comparisons showed that the nonshifters, on their work week compared to their off-work week, spent almost 2 h less in bed (406 ± 83 vs. 543 ± 24 min, p < .01) and slept nearly 2 h less (341 ± 82 vs. 448 ± 58 h, p < .01). There were no differences between the weeks for the shifters.
The finding of high variability in clock resetting under very consistent work schedules has many implications. Most important, it suggests that there may be few universal recommendations for the dilemmas of night work; what works for one person may not be helpful for another. Also, it underscores the many questions that remain regarding the relative importance of intrinsic (e.g., age, sex, morningness-eveningness) and extrinsic (e.g., light exposure, social interactions) factors that affect circadian adaptation to night work. Further refinements in the use of the melatonin profile to determine circadian time in a larger number of night workers in a variety of night work conditions and schedules will help to address these questions.
Melatonin Treatment of Night Workers
Although shift work intolerance may be an ideal disorder for melatonin treatment, there have been only two studies involving actual night workers (although several of the laboratory studies involving phase shifting may be very relevant). Because a large proportion of untreated night workers phase shift on their own (without treatment), and because of the variability in phase shifting, it may be necessary to focus on subjects who do not shift, or only partially shift, to observe a response to melatonin administration. Alternatively, a treatment response might be appreciated by measuring the rate of phase shift, hypothesizing that melatonin accelerates circadian adaptation even if the final phase position is the same; however, this strategy would require very frequent phase assessments, a strategy that is not very practical at this time.
For the initial analysis of our melatonin treatment trial (the experimental design was described earlier), we first estimated each subject's &dquo;normal&dquo; DLMO for a day-active schedule (off-work week) and then calculated the magnitude of the phase shift subjects were able to achieve on their night-work, day-sleep schedule, comparing it to the shift they made with placebo or no treatment. Figure 1 shows a summary of the results. Subjects 9 through 15 could be considered specific melatonin responders; they had very little or no phase shift in their DLMO with the placebo treatment but shifted at least 3 h with melatonin. Subjects 17 through 24 delayed their DLMO substantially on placebo alone, and melatonin did not augment the shift. Subjects 1, 2, and 4 advanced their DLMO equally on melatonin and placebo. Subjects 5 through 8 had no shift with either treatment. Several subjects seemed to be atypical. For example, Subject 3 was at distinctly different phases on two off-week determinations. Perhaps because of his differing starting phase, he advanced on the placebo trial and delayed on the melatonin trial. Subject 16 had a larger delay in her DLMO with placebo than with melatonin. In summary, a large proportion of night workers on a 7-70 schedule made substantial phase shifts at the end of a 7-day run without treatment or with placebo. Melatonin specifically augmented phase shifts in a subgroup of workers who did not shift with placebo alone.
At this time, there is only one other study of melatonin administration to night workers (Folkard et al., 1993) . The subjects were 7 police officers who worked a rotating schedule that included a run of 7 night shifts. They took melatonin (5 mg) or placebo (double-blind crossover design) at bedtime prior to 6 day sleeps (mean = 0642 h ± 7.6 min) and 4 subsequent night sleeps (mean = 0039 h ± 12.7 min). The outcome variables were sleep diaries, awake-time alertness ratings, and performance tests. Melatonin increased estimated total day sleep times by 20 min and produced a statistically significant elevation in sleep quality. These improvements in sleep were associated with increased alertness ratings in the second half of the night shift (from 0200 to 0600 h). The authors reported that melatonin treatment diminished psychomotor performance and increased the subjective burden of mental effort, but no data were presented on these points. There was a suggestion from the alertness data that melatonin phase delayed rhythms, but no physiological phase markers were used. Overall, the study produced some encouraging, but preliminary, results.
Dawson and coworkers (1995) conducted a simulated shift work study comparing bright light, melatonin (4 mg in three divided doses across the day-sleep period), and placebo in young subjects who stayed awake for 3 nights doing performance tests hourly. Circadian phase was monitored before and after the 3-night run by measuring the DLMO, and sleep was assessed actigraphically Core temperature and psychomotor performance also were assessed. There was an average 8.8-h phase delay with the light treatment (timed to induce a delay). The placebo and melatonin groups delayed 4.2 and 4.7 h, respectively. The failure of melatonin treatment to induce greater phase shifts than placebo might be related to the divided dose regimen that fell on both the advance and delay portions of the melatonin phase response curve , possibly canceling out a phase-shifting effect. In this study, both melatonin and light improved sleep measures, but perhaps by different mechanisms. Light treatment shifted the temperature rhythm, but melatonin must have improved sleep by a direct (nonphase-shifting) action.
Conclusions
Basic circadian rhythm science has provided the foundation for understanding the mechanisms underlying the sleep and alertness disorders experienced by totally blind people and night shift workers and has pointed the direction for intervention strategies. The phase-shifting effects of melatonin in humans are con-Figure 1. Dim light melatonin onsets (DLMOs) for 24 night shift workers on a &dquo;7-70&dquo; schedule. The open circles represent the phase at the end of a week off work during which the subjects had adopted a conventional sleep and activity schedule. The boxes represent the DLMOs at the end of a workweek, the open boxes represent the DLMOs after placebo treatment, and the filled boxes represent the DLMOs after melatonin treatment. Melatonin responders are subjects who had little or no shift with placebo treatment but who delayed after melatonin treatment. On the right, the direction and magnitude of the phase shift for both treatments are listed for each subject. sistent with phase shifting observed in animals at the cellular and behavioral levels. Some of the questions for clinical researchers at this time are as follows. What are the optimal parameters for melatonin administration (e.g., dose, timing, formulation)? Are the phaseshifting and sleep-promoting effects of melatonin sufficiently potent to have a clinical impact? Is melatonin safe for long-term use?
